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The current study is aimed at highlighting the impact of enterally or parenterally applied immunoglobulins (Igs) on
polyunsaturated fatty acid (PUFA) absorption in newborn pigs. Piglets were chosen as the appropriate model since they are
born agammaglobulinemic and any eﬀects of Ig addition can thus be easily monitored. Twenty-one, new born piglets were used
in the study. Plasma levels of PUFAs, ARA, DHA, and EPA dropped (similarly to that seen in human infants) by between 40
and 50% in newborn, unsuckled piglets fed an infant formula for 48 h. However, piglets fed the same infant formula but
supplied with immunoglobulins (Igs) either orally, by feeding piglets with swine or bovine colostrum, or intravenously, by i.u.a.
(intraumbilical artery) infusion of swine or human Ig preparations or swine serum, demonstrated improved growth and PUFA
levels similar to those observed at birth. The signiﬁcant positive correlation was found between the body weight gain, as well as
levels of ARA and EPA, and plasma immunoglobulins concentration. These results indicate the importance of the presence of Ig
in the blood for appropriate absorption of dietary PUFAs and probably other nutrients in newborn piglets. This may have an
impact on the dietary guidelines for human neonates, especially those born prematurely with low plasma Ig levels, since PUFAs
are important factors for brain development in early life.
1. Introduction
The omega-3 long-chain polyunsaturated fatty acid (PUFA),
docosahexaenoic acid (DHA), is an important component
for the development of the nervous system and the mainte-
nance of cognitive function [1, 2]. This is particularly true
in preterm infants, since the majority of foetal nervous sys-
tem structural development, such as cortical growth and gyr-
iﬁcation, occurs throughout the third trimester [3]. Along
with essential fatty acids, linoleic acid (LA) and alpha linoleic
acid (ALA), as well as omega-6 fatty acids such as arachi-
donic acid (ARA), PUFAs also contribute to a number of
physiological functions, including that of immunomodula-
tion [4, 5]. However, PUFAs are poorly digested and thus
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poorly absorbed in preterm infants due to the immaturity of
the gastrointestinal system and (developmental) exocrine
pancreatic insuﬃciency [6–9].
To minimize deﬁciencies in PUFAs, infant formulas are
often supplemented with LA, and important PUFAs such as
DHA and ARA [10, 11]. However, plasma concentrations
of DHA and ARA in preterm infants drop precipitously soon
after birth and remain low, despite massive parenteral and
enteral nutritional support [4, 5]. Since the fat in infant
formulas cannot be provided in an “absorbable” form
due to the risk of inﬂammation caused by fatty acids,
the fat must be provided in a stable triglyceride form.
The triglycerides in turn require hydrolysis by pancreatic
lipase to fatty acids and monoglycerides before absorption
and utilization in the body [12].
Puriﬁed plasma Igs for intravenous use are broadly used
in clinics to treat symptomatically diﬀerent sickness, to mod-
ulate various immunological pathways at both the humoral
and cellular levels, including inﬂammation, antigen presenta-
tion, cell growth, and apoptosis [13]. Administration of exog-
enous Igs demonstrated a high eﬃcacy in the treatment of
sepsis and acute lung injury in adults [14, 15]. Since preterm
neonates are at increased risk of life-threatening infections
and problems with regard to development of the nervous
system [16–19], the potential advantage of treatment with
exogenous Igs could be even greater than in adults. Unfortu-
nately, the eﬀects of Igs on the development of the central
nervous system are poorly understood.
In nature, transfer of Igs from the colostrum to the blood
in newborn piglets takes place in the gut mucosa, during the
ﬁrst 24 hours of life [20]. Previous studies from our lab have
shown that immunoglobulin supplementation in newborn,
healthy piglets who are naturally agammaglobulinemic at
birth could ensure appropriate brain development in terms
of cognitive function and improvements in neuronal plastic-
ity [21]. Since ARA and DHA are recognised as important,
indispensable factors for brain development, we have decided
to explore whether Igs can aﬀect the absorption of these
PUFAs.
The main aim of the study was to highlight the depen-
dency of PUFA absorption on the presence of immunoglob-
ulins in the blood of newborn piglets. Piglets were chosen as
an appropriate model since they belong to the ungulate fam-
ily and are born agammaglobulinemic, and thus the eﬀects of
Ig addition can be easily monitored.
2. Materials and Methods
All experimental procedures were approved by the
University of Lund Ethics Review Committee on Animal
Experiments (approval No. M142-14). All eﬀorts were made
to minimize animals’ suﬀering.
2.1. Animals. The experiment was carried out on crossbred
((Yorkshire x Swedish Landrace) x Hampshire) pigs (Sus
scrofa domesticus) obtained from a SPF local herd (Vindfälle
810, 268 68 Röstånga, Sweden). Twenty-one piglets, a mix-
ture of males and females, were randomly chosen to partake
in the experiment, directly after parturition from six sows.
The piglets were weighed, marked, and housed under a heat-
ing lamp (150W). The piglets were then transported to the
animal facility of the Dept. of Biology, Lund University.
2.2. Experimental Design. Sample size was estimated using
G∗Power software, version 3.1.9.4 [22] for a one-way
ANOVA at α = 0:05 with 95% power, assuming f ðeffect
sizeÞ = 2 and SD = 20, for seven study groups.
All piglets were implanted with a silastic catheter in one
of their umbilical arteries, under anesthesia with 0.5-1.5%
air mixture of Fluothane (Zeneca, Gothenburg, Sweden)
and O2 as a carrier gas, at approximately 0.5-1 l/min in a
close-circuit respiratory system (Komesaroﬀ Medical
Developments, Melbourne, Australia).
After baseline blood sampling, the piglets were random-
ized into seven experimental groups. Group IF (n = 6) was
fed an infant formula containing ARA (0.014 g/100ml)
and DHA (0.009 g/100ml) (Similac 24 Special Care with
iron manufactured by Abbott Nutrition, Lake Forest, IL,
USA). Group S-Col (n = 3) was fed swine colostrum
(EPA, DHA, and ARA content of 0.98, 0.90, and
0.44 g/100 g FA, respectively [23]). Group B-Col (n = 3)
was fed bovine colostrum (EPA, DHA, and ARA content
of 0.28, 0.02, and 0.48 g/100 g FA, respectively [24]). Group
IF-SS (n = 3) was fed the infant formula and given an
intraumbilical artery (i.u.a.) infusion of swine serum. The
swine serum was injected in three doses, at 5, 13, and
21 h after birth, 4, 5, and 7ml/kg bwt, respectively. Group
IF-Ig S (n = 3) was fed the infant formula and given an
i.u.a. infusion of puriﬁed porcine immunoglobulin (piglets
were infused, via the umbilical vein, 1540mg/kg bwt–
25ml of sterile Ig preparation/kg bwt). Group IF-Ig H
(n = 3) was fed the infant formula and given an i.u.a. infu-
sion of puriﬁed human immunoglobulin (piglets were
infused, via the umbilical artery, 2500mg/kg bwt–25ml of
sterile Ig preparation/kg bwt). All piglets were fed their
respective diets via a stomach tube in a volume of 10ml/kg
body weight, every two hours for up to 12 hours (six feed-
ings). After this, the piglets were fed exclusively with the
infant formula in a volume of 15ml/kg bwt every two hours
for up to 48hours (to the end of experiment). The piglets in
particular groups were kept together under a heating lamp.
In addition, unsuckled newborn piglets (Group NB, n = 9)
that were not subjected to any form of treatment were
sacriﬁced within 1 h after birth and included as controls.
The information on detailed dosing and source of immuno-
globulins, as well as on dietary PUFA levels, is presented in
Table 1. The schematic study design is provided in
Figure 1.
2.3. Blood Sample Collection. Baseline (0 hours) and ﬁnal
(48 hours) blood samples were collected via the umbilical
artery catheter and transferred to BD Vacutainer® glass tubes
coated with lithium heparin (BD Diagnostics, New Jersey,
USA). The collected samples were immediately placed on
ice before they were centrifuged at 3000 x g for 15 minutes
at 4°C, and plasma was separated and stored at -80°C until
further analysis.
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2.4. Quantiﬁcation of Free DHA, ARA, and EPA in Plasma.
For the measurement of free PUFA (μg/ml), 100μl of the
blood sample from each piglet was precipitated using 100μl
of internal standard (deuterated ARA, DHA, and EPA
obtained from Sigma-Aldrich) solution in IPA (POCh). After
that, it was acidiﬁed by addition of 100μl of 2% HCOOH.
Samples were subsequently extracted using 600μl of hexane
(Avantor Baker) and the organic layer was evaporated under
nitrogen. Samples were solubilized in 100μl of 5% NH4OH
in 65% MeOH and 10μl was injected into LC/MS. Samples
were then analysed using Waters Xevo TQ-S triple quadru-
pole MS coupled with Waters Acquity UPLC chromato-
graph. The column used was an ACQUITY UPLC BEH
C18 Column, 1.7μm, 2:1mm × 50mm thermostated in
60°C. Mobile phase A was 0.1% NH4OH in MQ water;
mobile phase B was pure LC/MS grade ACN (Avantor
Baker). A linear gradient was used, starting from 40% to
95% B over 1.7min. MS was operating in negative MRM
mode. Parameters were as follows: capillary voltage 3.2, des-
olvation temperature 500°C, desolvation gas (nitrogen) ﬂow
900 l/h, and cone gas ﬂow 150 l/h. Calibration and control
samples were prepared by spiking PUFA standards into
45mg/ml fatty acid-free BSA (Sigma-Aldrich, St. Louis,
MO, USA) solution in 0.9% NaCl.
2.5. Autopsy and Sample Collection. Following the 48 hour
feeding period, the piglets were euthanized by a single
dose of sodium pentobarbiturate (100mg/kg), i.u.a. At
autopsy specimens from the stomach, the duodenum,
ileum, and pancreas were collected, ﬂushed with ice-cold
saline, and immediately ﬁxed in Bouin’s solution for
48 hours. Samples were then dehydrated and embedded
into paraﬃn, according to standard histological techniques.
Prior to routine H&E (hematoxylin and eosin, Histolab,
Gothenburg, Sweden) staining, tissue blocks were sliced
into 5μm thick slices, using a rotor microtome. After
staining, samples were dehydrated and mounted onto a
slide, under a coverslip with DPX medium. A histological
analysis was done on each sample using a light microscope
(Olympus PROVIS, Tokyo, Japan).
2.6. Analyses of IgG Content. The concentration of swine,
bovine, and human IgG (μg/ml) in the plasma samples, as
well as in the swine serum, bovine, and swine colostrum
and the porcine Igs preparation, was analysed by a single
radial immunodiﬀusion [25], using antiporcine IgG pro-
duced in rabbits (Sigma P0916) and puriﬁed porcine IgG as
the standard (Sigma 14381), anti-bovine IgG produced in
rabbits (Sigma B5645) and puriﬁed bovine IgG as the stan-
dard (Sigma I5506), anti-human IgG produced in goat
(Sigma I1886) and puriﬁed human IgG as the standard
(Sigma I4506, all Sigma-Aldrich, St. Louis, MO, USA),
respectively.
2.7. Calculations and Statistics. Data are expressed as
mean ± SD. An ANOVA, followed by a Tukey post hoc
test for normally distributed datasets, and a Kruskal-
Wallis test followed by Dunn’s multiple comparison test
for datasets with nonparametric distribution (GraphPad
Prism, v 8.1.0) were used to assess statistical diﬀerences
between groups. To assess data distribution, Shapiro-Wilk
normality test was performed. Spearman’s correlation was
used to examine correlations between variables. Diﬀerences
were considered signiﬁcant if p ≤ 0:05.
3. Results
Blood levels of DHA, ARA, and EPA in newborn unsuckled
piglets (NB group) were around 78.5, 53.5, and 13.41μg/ml,
respectively (Figure 2). In piglets fed for 48 hours exclusively
with infant formula (IF group), a signiﬁcant decline in blood
DHA, ARA, and EPA was observed (p < 0:01) when com-
pared to the NB group. The blood levels of DHA, ARA, and
EPA in piglets which got any kind of immunoglobulin sup-
plementation (S-Col, B-Col, IF+SS, IF+IgS, and IF+IgH
groups) were not signiﬁcantly diﬀerent from those observed
in the NB group (Figure 2). In piglets supplemented i.u.a.
with swine serum (IF+SS group), the blood levels of both
DHA and ARA, but not EPA, were signiﬁcantly (p < 0:05)
higher than those observed in the IF group (Figure 2). Pig-
lets supplemented i.u.a. with swine immunoglobulins (IF
+IgS group) also demonstrated signiﬁcantly (p < 0:05)
higher levels of ARA, but not DHA and EPA, when com-
pared to the IF group (Figure 2). It is worth mentioning
that signiﬁcant positive correlation was found between
the blood levels of ARA and EPA and plasma immuno-
globulin concentration (Figure 3). No correlation was
found between blood DHA level and plasma immunoglob-
ulin concentration (Figure 3).
With regard to body weight gain, piglets in the IF group
demonstrated a signiﬁcant loss of body weight during the
48 hour feeding period when compared to the NB group
(p < 0:05) (Table 2). In fact, only piglets from the S-Col and
IF+IgS groups gained weight within the ﬁrst 48 hours of the
study, while those in the other experimental groups displayed
either an absence of body weight gain or weight loss
Table 1: IgG concentrations in swine and bovine colostrum, swine
serum, and swine and human Ig preparations. Newborn nonsuckled
piglets (NB) (n = 9); piglets fed for 48 hours with infant formula
(IF), (n = 6). Piglets fed for 48 hours with either only swine
colostrum (S-Col) (n = 3) or only bovine colostrum (B-Col) (n = 3).
Piglets fed infant formula supplemented i.u.a. with either swine
serum (IF-SS) (n = 3), swine immunoglobulins (IF-Ig S) (n = 3), or
human immunoglobulins (IF-Ig H) (n = 3).
Group
Dose (mg/kg bwt)
Swine IG Bovine IG Human IG
NB 0 h NA NA NA
IF NA NA NA
S-Col 6052.80 NA NA
B-Col NA 6549.60 NA
IF+SS 403.52 NA NA
IF+IgS 1540.08 NA NA
IF +IgH NA NA 2500
NA: not applicable.
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(Table 2). The signiﬁcant positive correlation was found
between the body weight gain and plasma immunoglobulin
concentration (Figure 3).
The histological examination of the small intestine and
pancreatic tissue did not reveal any signiﬁcant diﬀerences
between groups—data not shown.
4. Discussion
Several recent studies have shown that PUFA absorption and
thus their availability are critical factors for brain develop-
ment [26] in newborns. Their beneﬁts for the growth and
maturation of an infant’s brain and visual acuity are well
known, and the mechanisms of such eﬀects have been widely
investigated. PUFA supplementation has also been shown to
improve both cognitive [27] and psychomotor development
[28] in preterm human infants.
Recently, pig models have shown that the initial high
levels of PUFA observed at birth signiﬁcantly decrease
directly after birth and their recovery towards initial baseline
values is very diﬃcult to achieve by simple supplementation
of the infant formula with DHA or ARA [29]. At the same
time, the maintenance of optimal lipid composition and
metabolism in the brain is not only important during the
early stages of brain development and maturation from ges-
tation through childhood [30, 31], but also is crucial for
healthy brain aging [32–34].
So the question remains, why is supplementation of
infant formula with DHA and ARA only slightly eﬀective
in returning PUFA levels to those observed at birth [4, 5,
35] and how can one improve the absorption of PUFAs in
the gastrointestinal tract of newborns?
Since a previous study from our lab [21] demonstrated
that parenteral or enteral supplementation with IgG
improves brain development and behavior in a newborn
pig model, born agammaglobulinemic, we decided to investi-
gate how the absorption of PUFAs is related to the presence
of IgG in the blood and gastrointestinal tract.
A very narrow time frame exists (around 36 hours) dur-
ing which the possible eﬀects of immunoglobulins on the
absorption of PUFAs can be investigated, since it has to be
done when the piglets still have a so-called “open gut.” Gut
Unsuckled
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n = 9
NB 0 h IF S-Col B-Col IF-SS
Study design
The pigs were gavage fed with infant formula or colostrum, 10 ml/kg body weight, via a stomach tube every 2 h for up 
to 24 h (12 feedings). After first 24 hours, all piglets were fed with infant formula in a dose of 15 ml/kg bwt every 2 h 
as a nutrient up to 48 hours.
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Figure 1: Study design. Newborn nonsuckled piglets (NB) (n = 9); piglets fed for 48 hours with infant formula (IF) (n = 6); piglets fed for
48 hours with either swine colostrum (S-Col) (n = 3) or bovine colostrum (B-Col) (n = 3); piglets fed infant formula supplemented i.u.a.
with either swine serum (IF+SS) (n = 3), swine immunoglobulins (IF+IgS) (n = 3), or human immunoglobulins (IF+IgH) (n = 3).
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Figure 2: Blood levels of PUFA in piglets. Newborn nonsuckled piglets (NB) (n = 9); piglets fed for 48 hours with infant formula (IF) (n = 6);
piglets fed for 48 hours with either swine colostrum (S-Col) (n = 3) or bovine colostrum (B-Col) (n = 3); piglets fed infant formula
supplemented i.u.a. with either swine serum (IF+SS) (n = 3), swine immunoglobulins (IF+IgS), (n = 3), or human immunoglobulins
(IF+IgH) (n = 3). Individual values are shown for each experimental group (n = 3‐9). Capital letters given with results mean
signiﬁcant diﬀerences within the dot columns when p < 0:05.
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closure is the phenomenon which occurs approximately 36
hours after birth, prior to this, the gut enterocytes [36, 37]
are capable of absorbing intact IgG from the sow’s colostrum.
In fact, gut absorption is the only way in which ungulates are
able to get IgG into their circulation.
The current experiment indicated that the presence of Igs
in the blood is important for ensuring that PUFAs are
absorbed from the gut. Independently, immunoglobulins
oﬀered directly by feeding with colostrum or injected i.u.a.,
either as a preparation of swine or human IgG, as well swine
serum, ensure higher levels of DHA, ARA, and EPA in the
blood, 48 hours after birth. While in the piglets, not obtaining
any form of immunoglobulins, ARA, DHA, and EPA levels
remained between 40 and 50% lower than that observed in
newborn piglets or piglets treated with immunoglobulins.
It is interesting that the levels of EPA, which is synthe-
sized in the neonate, are lower in hypoimmunogenic animals
than in animals obtaining i.u.a. treatment with IgG. We
know that EPA is synthetized from the absorbed alpha-
linolenic acid (ALA), and this process’ eﬃciency is very
low. However, the IgG treatment led to the increase in EPA
plasma levels only after 48 hours and probably could regulate
the infant’s EPA synthesis. It seems that plasma immuno-
globulins not only ensure the absorption of PUFAs from
gut but also aﬀect essential fatty acid interactions and/or syn-
thesis as manifested by the increased level of EPA.
It is also worth mentioning that PUFA has a wide range
of metabolites, including eicosanoids, which are a large class
of highly potent regulatory lipid hormones, possessing a wide
range of biological functions. DHA and EPA are also parent
molecules of specialized proresolving lipid mediators
(SPMs). SPMs have anti-inﬂammatory and proresolving
characteristics and include protectins, D-series resolvins,
and maresins derived from DHA and EPA via cyclooxygen-
ase and lipoxygenase pathways [38, 39]. Deﬁciencies in the
levels of the n-3 PUFAs, DHA, and EPA, which are parent
molecules of SPMs, could impair B-cell development, diﬀer-
entiation, and maturation, with further impairments in
immunoglobulin synthesis [40, 41]. Thus, the development
of adaptive immunity which takes place in infants could be
impaired with an n-3 PUFA deﬁcit. Considering these obser-
vations, the role of immunoglobulins becomes even more
important.
The species speciﬁcity of immunoglobulins is less impor-
tant since both human and bovine immunoglobulins aﬀect
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Figure 3: Scatterplots showing correlation between changes in piglets’ body weight gain and plasma PUFA concentrations with IgG plasma
concentrations; Spearman correlations (r). Data expressed as individual values at the end of the treatment period, for all study groups, except
NB (newborn nonsuckled piglets).
Table 2: Blood levels of IgG and PUFA and body weight gain in
piglets. Newborn nonsuckled piglets (NB) (n = 9); piglets fed for
48 hours with infant formula (IF) (n = 6). Piglets fed for 48 hours
alone either swine colostrum (S-Col) (n = 3) or bovine colostrum
(B-Col) (n = 3). Piglets fed infant formula supplemented i.u.a.
either with swine serum (IF+SS) (n = 3), swine immunoglobulins
(IF+IgS) (n = 3), or human immunoglobulins (IF+IgH) (n = 3).
Data are presented as mean ± SD, (n = 3‐9). a = bovine IgG,
b = human IgG. Superscripted capital letters given with results
imply signiﬁcant diﬀerences within the columns when p < 0:05.
Groups IgG (mg/ml) Body weight gain (kg)
NB 0 h 0:087 ± 0:045 NA
IF 0:076 ± 0:024 −0:85 ± 0:07A
S-Col 9:77 ± 0:54 0:50 ± 0:08B
B-Col 6:33 ± 0:86(a) 0:00 ± 0:05C
IF+SS 1:78 ± 1:07 −0:20 ± 0:04D
IF+Ig S 6:56 ± 1:30 0:30 ± 0:02E
IF+Ig H 0:13 ± 0:02(b) −0:20 ± 0:07D
NA: not applicable.
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PUFA absorption similarly to swine immunoglobulins. How-
ever, with regard to body weight gain, which is one of the
main factors for the assessment of newborn pig development,
as well as for human neonates, only high doses of swine
immunoglobulins (swine colostrum feeding or i.u.a. injection
of swine Igs preparation) appeared to be suﬃcient to ensure
body weight gain in the preterm piglets. This ﬁnding could
be explained by the inability of foreign immunoglobulins to
inﬂuence the gut cellular structure [42] and brain-gut inter-
actions [21, 43], in the same manner as swine Igs. It is worth
pointing out that malabsorption of dietary PUFAs and
evident growth retardation observed in preterm human
infants [44] can be associated with impaired absorption of
other nutrients, including macromolecules, as well as in Ig-
deprived piglets. Thus, our present data supports the sugges-
tions postulated by Ahmadi et al. [45] and Juhl et al. [46]
about dietary supplementation of preterm children with
bovine colostrum.
The data presented here might have implications for the
formulation/revision of nutritional guidelines for preterm
and newborn children, with special emphasis on the impor-
tance of immunoglobulins for appropriate PUFA (probably
other nutrients as well) absorption and growth.
5. Conclusions
The study presented in the manuscript was planned and
designed as an explorative experiment, carried out on the
reliable agammoglobulinemic newborn pig model, in order
to reveal whether the maternal immunoglobulins (speciﬁ-
cally IgG) of diﬀerent origin administered via diﬀerent
administration routes have any eﬀect on the absorption of
essential fatty acids. The main strength of this study is the
novel approach to immunonoglobulins and their relation-
ship to dietary fat absorption. Analysis of both n-3 and n-6
PUFAs in the agammaglobulinemic newborn pig model is
another key strength of this study.
The main limitation of this study is the relatively small
sample size and observational character of the ﬁndings. Fur-
ther, long-term studies involving more animals and large
panel of molecular techniques, which could help to elucidate
mechanisms underlying the observed eﬀects, are currently
being planned. We hope that they will enable the veriﬁcation
and explanation of obtained results.
In summary, we identiﬁed a signiﬁcant inﬂuence of
immunoglobulin supplementation on PUFA absorption dur-
ing early postnatal development.
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